Similarly, JDP2 prevents AP-1 transcription interfering with the oncogenic properties of c-Jun [20], but in JDP2 transgenic mice, JDP2 expression in the liver promotes hepatocellular carcinoma [21]. The gene discussed is JUN; the disease is hepatocellular carcinoma.